NovAccess Global Inc. Logo

NovAccess Global Inc.

XSNX

(1.8)
Stock Price

0,01 USD

-614.98% ROA

12.07% ROE

-0.4x PER

Market Cap.

491.088,00 USD

-30.61% DER

0% Yield

0% NPM

NovAccess Global Inc. Stock Analysis

NovAccess Global Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

NovAccess Global Inc. Fundamental Stock Analysis
# Analysis Rating
1 ROE

The stock's ROE exceeds expectations (18.42%), revealing strong profitability and efficient use of shareholders' equity, making it an attractive investment opportunity.

2 PBV

The stock's low PBV ratio (-0.11x) suggests it's undervalued, making it an attractive opportunity for investors.

3 DER

The stock has a minimal amount of debt (-31%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

4 Graham Number

The Graham number analysis indicates that this company's stock price is likely undervalued, raising prospects for a favorable investment opportunity.

5 ROA

The stock's ROA (-614.98%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

6 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

7 Net Profit Growth

Despite the passage of five years, this company's net profit has not shown any improvement, highlighting a lack of growth and making it a less appealing investment prospect.

8 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

9 Dividend Growth

The company's dividend growth has shown no improvement in the past three years, making it a less attractive investment option for those seeking increasing returns.

10 Dividend

The company's lack of dividends in the past three years may concern investors seeking regular income.

11 Buffet Intrinsic Value

The company's stock shows signs of being overvalued (0) according to Warren Buffett's formula, indicating a potential downside as its market price exceeds its estimated intrinsic value.

NovAccess Global Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

NovAccess Global Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

NovAccess Global Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

NovAccess Global Inc. Revenue
Year Revenue Growth
2001 0
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 8.000 100%
2007 6.880 -16.28%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 393.522 100%
2015 1.215.632 67.63%
2016 750.556 -61.96%
2017 1.172.972 36.01%
2018 665.017 -76.38%
2019 1.608.723 58.66%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

NovAccess Global Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2001 0
2002 0 0%
2003 0 0%
2004 129.493 100%
2005 501.423 74.17%
2006 949.472 47.19%
2007 435.534 -118%
2008 0 0%
2009 3.316.853 100%
2010 292.999 -1032.04%
2011 282.492 -3.72%
2012 122.673 -130.28%
2013 426.371 71.23%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 186.115 100%
2023 160.656 -15.85%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

NovAccess Global Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2001 0
2002 47.297 100%
2003 145.845 67.57%
2004 1.398.299 89.57%
2005 859.569 -62.67%
2006 2.334.448 63.18%
2007 2.087.031 -11.85%
2008 4.004.970 47.89%
2009 3.316.853 -20.75%
2010 1.470.731 -125.52%
2011 946.459 -55.39%
2012 645.546 -46.61%
2013 532.624 -21.2%
2014 527.926 -0.89%
2015 520.800 -1.37%
2016 482.779 -7.88%
2017 453.235 -6.52%
2018 428.338 -5.81%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

NovAccess Global Inc. EBITDA
Year EBITDA Growth
2001 -354.530
2002 -47.297 -649.58%
2003 -145.845 67.57%
2004 -1.547.168 90.57%
2005 -1.364.971 -13.35%
2006 -3.281.088 58.4%
2007 -3.663.258 10.43%
2008 -4.033.014 9.17%
2009 2.805.238 243.77%
2010 -1.763.686 259.06%
2011 -1.228.951 -43.51%
2012 -768.219 -59.97%
2013 -958.995 19.89%
2014 -417.628 -129.63%
2015 -239.653 -74.26%
2016 -206.253 -16.19%
2017 -71.676 -187.76%
2018 -202.014 64.52%
2019 207.860 197.19%
2020 -5.917.416 103.51%
2021 -2.682.716 -120.58%
2022 -2.328.649 -15.2%
2023 -2.253.752 -3.32%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

NovAccess Global Inc. Gross Profit
Year Gross Profit Growth
2001 0
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 8.000 100%
2007 6.880 -16.28%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 110.298 100%
2015 303.228 63.63%
2016 276.526 -9.66%
2017 381.559 27.53%
2018 226.324 -68.59%
2019 752.558 69.93%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

NovAccess Global Inc. Net Profit
Year Net Profit Growth
2001 305.485
2002 -47.297 745.89%
2003 -145.868 67.58%
2004 -1.509.068 90.33%
2005 -1.400.839 -7.73%
2006 -3.441.940 59.3%
2007 -1.289.497 -166.92%
2008 -4.058.952 68.23%
2009 -10.634.133 61.83%
2010 -2.210.603 -381.05%
2011 -1.117.654 -97.79%
2012 -1.555.194 28.13%
2013 -2.522.382 38.34%
2014 -1.949.887 -29.36%
2015 -1.320.648 -47.65%
2016 -242.866 -443.78%
2017 -498.663 51.3%
2018 -3.969.406 87.44%
2019 2.343.982 269.34%
2020 -6.800.751 134.47%
2021 -2.890.346 -135.29%
2022 591.188 588.91%
2023 -3.118.556 118.96%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

NovAccess Global Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2001 398
2002 -62 750.82%
2003 -22 -177.27%
2004 -13 -69.23%
2005 -11 -18.18%
2006 -28 59.26%
2007 -9 -200%
2008 -24 62.5%
2009 -56 57.14%
2010 -11 -460%
2011 -5 -100%
2012 -6 16.67%
2013 -7 14.29%
2014 -4 -133.33%
2015 -2 -50%
2016 0 0%
2017 -1 0%
2018 -3 100%
2019 2 300%
2020 -4 125%
2021 0 0%
2022 0 0%
2023 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

NovAccess Global Inc. Free Cashflow
Year Free Cashflow Growth
2001 40.834
2002 -3.370 1311.69%
2003 -27.372 87.69%
2004 -1.438.900 98.1%
2005 -1.231.645 -16.83%
2006 -4.042.014 69.53%
2007 -1.022.906 -295.15%
2008 -8.424.099 87.86%
2009 -2.878.501 -192.66%
2010 -1.577.395 -82.48%
2011 -1.123.871 -40.35%
2012 -382.549 -193.78%
2013 -474.454 19.37%
2014 -368.368 -28.8%
2015 -207.068 -77.9%
2016 -172.598 -19.97%
2017 -45.616 -278.37%
2018 -123.966 63.2%
2019 -8.826 -1304.55%
2020 -93.190 90.53%
2021 -682.333 86.34%
2022 -903.489 24.48%
2023 -113.276 -697.6%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

NovAccess Global Inc. Operating Cashflow
Year Operating Cashflow Growth
2001 40.834
2002 -3.370 1311.69%
2003 -27.372 87.69%
2004 -1.436.630 98.09%
2005 -1.049.650 -36.87%
2006 -1.942.278 45.96%
2007 -843.416 -130.29%
2008 -2.695.476 68.71%
2009 -2.862.327 5.83%
2010 -1.347.395 -112.43%
2011 -1.117.818 -20.54%
2012 -379.240 -194.75%
2013 -441.718 14.14%
2014 -368.368 -19.91%
2015 -207.068 -77.9%
2016 -171.972 -20.41%
2017 -44.844 -283.49%
2018 -123.966 63.83%
2019 -6.542 -1794.93%
2020 -93.190 92.98%
2021 -682.333 86.34%
2022 -903.489 24.48%
2023 -113.276 -697.6%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

NovAccess Global Inc. Capital Expenditure
Year Capital Expenditure Growth
2001 0
2002 0 0%
2003 0 0%
2004 2.270 100%
2005 181.995 98.75%
2006 2.099.736 91.33%
2007 179.490 -1069.83%
2008 5.728.623 96.87%
2009 16.174 -35318.72%
2010 230.000 92.97%
2011 6.053 -3699.77%
2012 3.309 -82.93%
2013 32.736 89.89%
2014 0 0%
2015 0 0%
2016 626 100%
2017 772 18.91%
2018 0 0%
2019 2.284 100%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

NovAccess Global Inc. Equity
Year Equity Growth
2001 -366.906
2002 -414.203 11.42%
2003 2.349 17733.16%
2004 -24.049 109.77%
2005 -532.549 95.48%
2006 6.295.765 108.46%
2007 5.429.572 -15.95%
2008 9.427.925 42.41%
2009 482.810 -1852.72%
2010 -419.160 215.19%
2011 -525.798 20.28%
2012 -150.898 -248.45%
2013 -792.626 80.96%
2014 -902.784 12.2%
2015 -879.251 -2.68%
2016 -840.448 -4.62%
2017 -1.044.224 19.51%
2018 -4.637.683 77.48%
2019 -2.235.951 -107.41%
2020 -3.569.730 37.36%
2021 -3.928.094 9.12%
2022 -4.653.066 15.58%
2023 -6.232.956 25.35%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

NovAccess Global Inc. Assets
Year Assets Growth
2001 0
2002 0 0%
2003 2.349 100%
2004 72.114 96.74%
2005 441.684 83.67%
2006 6.884.464 93.58%
2007 5.742.260 -19.89%
2008 9.924.835 42.14%
2009 1.375.649 -621.47%
2010 525.671 -161.69%
2011 204.023 -157.65%
2012 600.754 66.04%
2013 151.512 -296.51%
2014 69.451 -118.16%
2015 94.867 26.79%
2016 65.902 -43.95%
2017 48.294 -36.46%
2018 154.181 68.68%
2019 215.192 28.35%
2020 178 -120794.38%
2021 208.134 99.91%
2022 124.901 -66.64%
2023 177.027 29.45%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

NovAccess Global Inc. Liabilities
Year Liabilities Growth
2001 366.906
2002 414.203 11.42%
2003 0 0%
2004 96.163 100%
2005 974.233 90.13%
2006 588.699 -65.49%
2007 312.688 -88.27%
2008 496.910 37.07%
2009 892.839 44.34%
2010 944.831 5.5%
2011 729.821 -29.46%
2012 751.652 2.9%
2013 944.138 20.39%
2014 972.235 2.89%
2015 974.118 0.19%
2016 906.350 -7.48%
2017 1.092.518 17.04%
2018 4.791.864 77.2%
2019 2.451.143 -95.5%
2020 3.569.908 31.34%
2021 4.136.228 13.69%
2022 4.777.967 13.43%
2023 6.409.983 25.46%

NovAccess Global Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
-0.05
Price to Earning Ratio
-0.4x
Price To Sales Ratio
0x
POCF Ratio
-0.65
PFCF Ratio
-0.74
Price to Book Ratio
-0.07
EV to Sales
0
EV Over EBITDA
-0.75
EV to Operating CashFlow
-3.5
EV to FreeCashFlow
-3.5
Earnings Yield
-2.5
FreeCashFlow Yield
-1.36
Market Cap
0,00 Bil.
Enterprise Value
0,00 Bil.
Graham Number
0.58
Graham NetNet
-0.3

Income Statement Metrics

Net Income per Share
-0.05
Income Quality
0.22
ROE
0.18
Return On Assets
-45.56
Return On Capital Employed
0.34
Net Income per EBT
1
EBT Per Ebit
0.36
Ebit per Revenue
0
Effective Tax Rate
-0.46

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0
Operating Profit Margin
0
Pretax Profit Margin
0
Net Profit Margin
0

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.03
Free CashFlow per Share
-0.03
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
0.25
Return on Tangible Assets
-6.15
Days Sales Outstanding
0
Days Payables Outstanding
2328.55
Days of Inventory on Hand
0
Receivables Turnover
0
Payables Turnover
0.16
Inventory Turnover
0
Capex per Share
0

Balance Sheet

Cash per Share
0,00
Book Value per Share
-0,29
Tangible Book Value per Share
-0.29
Shareholders Equity per Share
-0.29
Interest Debt per Share
0.16
Debt to Equity
-0.31
Debt to Assets
10.78
Net Debt to EBITDA
-0.59
Current Ratio
0.03
Tangible Asset Value
-0,01 Bil.
Net Current Asset Value
-0,01 Bil.
Invested Capital
-0.31
Working Capital
-0,01 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
0
Debt to Market Cap
3.88

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

NovAccess Global Inc. Dividends
Year Dividends Growth

NovAccess Global Inc. Profile

About NovAccess Global Inc.

NovAccess Global Inc., a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. The company specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. NovAccess Global Inc. was incorporated in 1997 and is headquartered in Chesterland, Ohio.

CEO
Dr. Dwain K. Morris-Irvin M.P.
Employee
3
Address
8834 Mayfield Road
Chesterland, 44026

NovAccess Global Inc. Executives & BODs

NovAccess Global Inc. Executives & BODs
# Name Age
1 Dr. Christopher Wheeler Ph.D.
President of Stemvax Therapeutics
70
2 Dr. Dwain K. Morris-Irvin M.P.H., MPH, Ph.D.
Chief Executive Officer & Director
70
3 Mr. Neil J. Laird
Chief Financial Officer
70

NovAccess Global Inc. Competitors